Hauser WA, Annegers JF, Elveback LR. Mortality in patients with epilepsy. Epilepsia. 1980;21:399–412.
Cockerell OC, Johnson AL, Sander JW, Hart YM, Goodridge DM, Shorvon SD. Mortality from epilepsy: results from a prospective population-based study. Lancet. 1994;344:918–21.
Nashef L, Fish DR, Sander JW, Shorvon SD. Incidence of sudden unexpected death in an adult outpatient cohort with epilepsy at a tertiary referral centre. J Neurol Neurosurg Psychiatr. 1995;58:462–4.
Nilsson L, Tomson T, Farahmand BY, Diwan V, Persson PG. Cause-specific mortality in epilepsy: a cohort study of more than 9,000 patients once hospitalized for epilepsy. Epilepsia. 1997;38:1062–8.
Chen Z, Liew D, Kwan P. Excess mortality and hospitalized morbidity in newly treated epilepsy patients. Neurology. 2016;87:718–25.
Article PubMed PubMed Central Google Scholar
Moon H-J, Lee H, Yoon D, Koo YS, Shin J-Y, Lee S-Y. Premature mortality and causes of death among people with epilepsy: a nationwide population-based incident cohort study. Neurology. 2023;100:e2060–70.
Article PubMed PubMed Central Google Scholar
Zieliński JJ. Epilepsy and mortality rate and cause of death. Epilepsia. 1974;15:191–201.
Ding D, Wang W, Wu J, Ma G, Dai X, Yang B, et al. Premature mortality in people with epilepsy in rural China: a prospective study. Lancet Neurol. 2006;5:823–7.
Nei M, Ho RT, Sperling MR. EKG abnormalities during partial seizures in refractory epilepsy. Epilepsia. 2000;41:542–8.
Rugg-Gunn FJ, Simister RJ, Squirrell M, Holdright DR, Duncan JS. Cardiac arrhythmias in focal epilepsy: a prospective long-term study. Lancet. 2004;364:2212–9.
Nei M. Cardiac effects of seizures. Epilepsy Curr. 2009;9:91–5.
Article PubMed PubMed Central Google Scholar
Janszky I, Hallqvist J, Tomson T, Ahlbom A, Mukamal KJ, Ahnve S. Increased risk and worse prognosis of myocardial infarction in patients with prior hospitalization for epilepsy–the Stockholm Heart Epidemiology Program. Brain. 2009;132:2798–804.
Centers for Disease Control and Prevention (CDC). Comorbidity in adults with epilepsy—United States, 2010. MMWR Morb Mortal Wkly Rep. 2013;62:849–53.
Bardai A, Lamberts RJ, Blom MT, Spanjaart AM, Berdowski J, van der Staal SR, et al. Epilepsy is a risk factor for sudden cardiac arrest in the general population. PLoS ONE. 2012;7: e42749.
Article PubMed PubMed Central Google Scholar
Lamberts RJ, Blom MT, Wassenaar M, Bardai A, Leijten FS, de Haan G-J, et al. Sudden cardiac arrest in people with epilepsy in the community: circumstances and risk factors. Neurology. 2015;85:212–8.
Article PubMed PubMed Central Google Scholar
Bardai A, Blom MT, van Noord C, Verhamme KM, Sturkenboom MCJM, Tan HL. Sudden cardiac death is associated both with epilepsy and with use of antiepileptic medications. Heart. 2015;101:17–22.
Stefani A, Spadoni F, Giacomini P, Lavaroni F, Bernardi G. The effects of gabapentin on different ligand- and voltage-gated currents in isolated cortical neurons. Epilepsy Res. 2001;43:239–48.
Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow R, Woodruff GN. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem. 1996;271:5768–76.
Olkkola KT, Ahonen J. Midazolam and other benzodiazepines. Handb Exp Pharmacol. 2008;335–60.
Guldiken B, Rémi J, Noachtar S. Cardiovascular adverse effects of phenytoin. J Neurol. 2016;263:861–70.
Nei M, Mintzer S, Skidmore C, Sperling MR, Ho RT. Heart rate and blood pressure in sudden unexpected death in epilepsy (SUDEP). Epilepsy Res. 2016;122:44–6.
Nass RD, Hampel KG, Elger CE, Surges R. Blood pressure in seizures and epilepsy. Front Neurol. 2019;10:501.
Article PubMed PubMed Central Google Scholar
Pendyala VV, Pribil S, Schaal V, Sharma K, Jagadesan S, Yu L, et al. Effects of acute and chronic gabapentin treatment on cardiovascular function of rats. Cells. 2023;12.
Pan Y, Davis PB, Kaebler DC, Blankfield RP, Xu R. Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy. Cardiovasc Diabetol. 2022;21:170.
Article PubMed PubMed Central Google Scholar
Chen W, Thomas J, Sadatsafavi M, FitzGerald JM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med. 2015;3:631–9.
Hinnell C, Williams J, Metcalfe A, Patten SB, Parker R, Wiebe S, et al. Health status and health-related behaviors in epilepsy compared to other chronic conditions—a national population-based study. Epilepsia. 2010;51:853–61.
Janousek J, Barber A, Goldman L, Klein P. Obesity in adults with epilepsy. Epilepsy Behav. 2013;28:391–4.
Lee-Lane E, Torabi F, Lacey A, Fonferko-Shadrach B, Harris D, Akbari A, et al. Epilepsy, antiepileptic drugs, and the risk of major cardiovascular events. Epilepsia. 2021;62:1604–16.
Zaccara G, Lattanzi S, Brigo F. Cardiac adverse effects of antiseizure medications. Expert Opin Drug Saf. 2022;21:641–52.
Renoux C, Dell’Aniello S, Saarela O, Filion KB, Boivin J-F. Antiepileptic drugs and the risk of ischaemic stroke and myocardial infarction: a population-based cohort study. BMJ Open. 2015;5: e008365.
Article PubMed PubMed Central Google Scholar
Josephson CB, Wiebe S, Delgado-Garcia G, Gonzalez-Izquierdo A, Denaxas S, Sajobi TT, et al. Association of enzyme-inducing antiseizure drug use with long-term cardiovascular disease. JAMA Neurol. 2021;78:1367–74.
Mayer J, Mbizvo GK, Bucci T, Marson A, Lip GYH. Association of antiseizure medications and adverse cardiovascular events: a global health federated network analysis. Epilepsia. 2024;65:1264–74.
Li J, Shlobin NA, Thijs RD, Sylvestre M-P, Josephson CB, Deacon C, et al. Antiseizure medications and cardiovascular events in older people with epilepsy. JAMA Neurol. 2024;81:1178–86.
Lopinto-Khoury C, Mintzer S. Antiepileptic drugs and markers of vascular risk. Curr Treat Opt Neurol. 2010;12:300–8.
Nicolo J-P, Chen Z, Nightscales R, O’Brien TJ, Kwan P. Identification of factors associated with new-onset vascular disease in patients admitted for video-EEG monitoring: a longitudinal cohort study. Epilepsy Behav. 2022;135: 108883.
Tan T-Y, Lu C-H, Chuang H-Y, Lin T-K, Liou C-W, Chang W-N, et al. Long-term antiepileptic drug therapy contributes to the acceleration of atherosclerosis. Epilepsia. 2009;50:1579–86.
Chuang Y-C, Chuang H-Y, Lin T-K, Chang C-C, Lu C-H, Chang W-N, et al. Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis. Epilepsia. 2012;53:120–8.
Pikuleva IA. Cholesterol-metabolizing cytochromes P450. Drug Metab Dispos. 2006;34:513–20.
Comments (0)